List of Model N Medicaid Customers
San Mateo, 94404, CA,
United States
Since 2010, our global team of researchers has been studying Model N Medicaid customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Model N Medicaid for Governance, Risk and Compliance from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Model N Medicaid for Governance, Risk and Compliance include: Janssen United States, a United States based Life Sciences organisation with 9000 employees and revenues of $34.00 billion, Salix Pharmaceuticals, a United States based Life Sciences organisation with 7100 employees and revenues of $1.90 billion, Novo Nordisk US, a United States based Life Sciences organisation with 7257 employees and revenues of $1.75 billion and many others.
Contact us if you need a completed and verified list of companies using Model N Medicaid, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Model N Medicaid customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Janssen United States | Life Sciences | 9000 | $34.0B | United States | Model N | Model N Medicaid | Governance, Risk and Compliance | 2005 | n/a |
In 2005, Janssen United States implemented Model N Medicaid to manage Medicaid claims calculations, validations, payment approvals and to generate required ROSI/PQAS reports supporting federal and state rebate compliance. The deployment positioned Model N Medicaid within the Governance, Risk and Compliance category to support finance and regulatory business functions responsible for government rebate submissions and filings.
The implementation centered on the Model N Medicaid Claims Processing application, with configured modules for claims calculations, automated validation rules, payment approval workflows and integrated reporting for ROSI and PQAS outputs. Automation of validation logic and embedded reporting workflows enabled a single application to perform calculation, exception detection and report generation tasks typical of Medicaid rebate management.
Operational scope covered finance and regulatory teams responsible for Medicaid rebate compliance, including preparation of audit-ready government filings for federal and state agencies. Governance was adapted to incorporate Model N Medicaid approval gates and validation-driven exception handling into existing rebate processes, and the system delivered outcomes that included reduced analyst workload, increased payment accuracy and improved audit-readiness for government filings as reported.
|
|
|
Novo Nordisk US | Life Sciences | 7257 | $1.8B | United States | Model N | Model N Medicaid | Governance, Risk and Compliance | 2006 | n/a |
In 2006 Novo Nordisk Inc. implemented Model N Medicaid Claims Processing, deploying Model N Medicaid within its Governance, Risk and Compliance tooling to automate Medicaid rebate administration in the United States. The implementation targeted finance and government pricing and compliance functions, establishing a centralized system to manage Medicaid and state supplemental claims across U.S. operations.
The Model N Medicaid Claims Processing deployment focused on claims ingestion, validation, rebate calculation and regulatory reporting capabilities. Configuration emphasized automated validation rules, structured rebate calculation workflows and standardized reporting outputs to support finance and compliance use cases, with Model N Medicaid used as the authoritative system for Medicaid rebate computations and claim lifecycle orchestration.
Governance and process changes accompanied the rollout, aligning finance, government pricing and compliance workflows to the new application and formalizing timing and validation checkpoints for rebate submissions. The implementation improved validation and timely reporting of rebate claims, enabling more accurate Medicaid rebate calculations and stronger regulatory compliance.
|
|
|
Salix Pharmaceuticals | Life Sciences | 7100 | $1.9B | United States | Model N | Model N Medicaid | Governance, Risk and Compliance | 2007 | n/a |
In 2007, Salix Pharmaceuticals implemented Model N Medicaid as part of a broader adoption of the Model N Revenue Management suite. The implementation targeted Governance, Risk and Compliance functions to centralize government pricing calculations and statutory reporting for the United States market.
Configuration emphasized the Model N Medicaid application for Medicaid and Average Manufacturer Price AMP reporting, alongside revenue management capabilities to automate government pricing calculations. Functional modules included Medicaid and AMP reporting workflows, pricing data consolidation, and rules-based calculation engines aligned with government pricing compliance. These modules replaced manual spreadsheet processes and introduced automated calculation and reporting pipelines.
Operational coverage focused on the finance and government pricing compliance organization at Salix Pharmaceuticals in the United States. The deployment supported regular regulatory reporting cycles and the adoption of regulatory updates, with Model N Medicaid instrumented into existing reporting workflows to produce statutory outputs. Integrations are described at the workflow level, with operational handoffs between pricing calculation modules and statutory reporting processes rather than named external systems.
Governance and process restructuring standardized compliance workflows and reduced manual touchpoints, outcomes that included faster regulatory update adoption and lower analyst burden as stated. Model N Medicaid served as the core compliance ledger within the Model N Revenue Management suite for Medicaid pricing and AMP reporting at Salix Pharmaceuticals.
|
Buyer Intent: Companies Evaluating Model N Medicaid
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||